CIK 0001738021 · Non-accelerated filer<br>Smaller reporting company
Compass Therapeutics, Inc.
Sign in to watch- Ticker
- CMPX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8099
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- Former names
- Olivia Ventures, Inc.
- 4 Grant or award CFO acquired 400,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 49,198 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT gave up 44,782 shares (to pay taxes)
- 4 Grant or award Chief Executive Officer acquired 1,753,125 shares (grant or award)
- 4 Grant or award President of R&D acquired 637,500 shares (grant or award)
- 4 Shares withheld for taxes Chief Operating Officer gave up 64,415 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 44,025 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CHIEF EXECUTIVE OFFICER bought 10,000 shares at $3.37 ($33,700)
Page 3 of 8 · 142 filings